[1]
A. Habibi, S. Z. Risqiyani, and D. A. S. Putri, “THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR/CAS9 AS PROSTATE CANCER THERAPY”, JIMKI, vol. 9, no. 1, pp. 23-37, Jul. 2021.